A failed trial can conceal a useful clue. PhaseV uses causal machine learning to look for it, then helps drug developers test a better design before committing patients, time and money.

An aerospace engineer crossed into neuroscience, learned to respect biology's refusal to behave, and built a company around a deceptively practical idea: a clinical trial should be allowed to learn.